SEC Tracker
Get the app

Dermata Therapeutics DRMA

Dermata Therapeutics files a prospectus for 933,064 shares

Securities offering

Form
424B3
Filed
Importance
Routine
  1. 933,064 shares of common stock
  2. 1,361,470 pre-funded warrant shares
  3. 2,294,534 Series E warrant shares
  4. 2,294,534 Series F warrant shares

Written from the 424B3 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Dermata Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Oragenics OGEN public float $3M, Jun 30, 2025
  2. MetaVia MTVA public float $3M, Jun 30, 2025
  3. Inhibitor Therapeutics INTI public float $3M, Jun 30, 2025
  4. PTC Therapeutics PTCT public float $3M, Jun 30, 2025
  5. Integrated Biopharma INBP public float $3M, Dec 31, 2025